# Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers

> **NCT07754279** · PHASE1 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 16 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** MMH-522

## Key facts

- **NCT ID:** NCT07754279
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-12
- **Primary completion:** 2026-04-16
- **Final completion:** 2026-05-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07754279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07754279, "Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07754279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*